Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Clinical trial NCT01585558 · COMPLETED

Trial details

NCT number: NCT01585558
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrophy Vaginal Diseases

Start date: 2006-05-16
Primary completion: 2008-08-19
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.